비교리스트

 카트 문의
시장보고서
상품코드
1586348

구획증후군 치료 시장, 규모, 점유율, 동향, 산업 분석 보고서 : 증후군 유형별, 치료 유형별, 투여 경로별, 유통 채널별, 지역별 - 시장 예측(2024-2032년)

Compartment Syndrome Treatment Market Size, Share, Trends, Industry Analysis Report: By Syndrome Type, Treatment Type, Route of Administration, Distribution Channel, and Region - Market Forecast, 2024-2032
발행일: | 리서치사: Polaris Market Research | 페이지 정보: 영문 118 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면, 세계 구획증후군 치료 시장 규모는 2032년까지 3억 8,765만 달러에 달할 것으로 예상됩니다. 이 조사 보고서는 현재 시장 역학에 대한 자세한 통찰력과 미래 시장 성장에 대한 분석을 제공합니다.

구획증후군 치료 시장의 성장은 이 질환에 대한 인식 증가, 의료 기술의 발전, 외상성 부상 발생률 증가, 구획증후군을 유발하는 만성 질환의 유병률 증가에 기인합니다. 또한, 수술 방법의 개선, 첨단 상처 관리 제품과 같은 혁신적인 치료 옵션의 개발, 최소 침습 수술에 대한 수요 증가도 시장 성장의 원동력이 되고 있습니다.

서비스 소외 지역에 대한 시장 접근성 확대와 인공지능, 로봇공학 등 신기술의 치료 계획 도입은 예측 기간 동안 시장에 기회를 가져다 줄 것으로 예상됩니다. 효과적이고 표적화된 치료를 위한 개인 맞춤형 의료와 향상된 진단에 대한 관심이 높아지는 것은 향후 시장의 주요 트렌드로 부상할 것으로 보입니다. 전반적으로, 구획증후군 치료 시장은 지속적인 발전과 의료 투자 증가로 인해 크게 성장할 것으로 예상됩니다.

구획증후군 치료 시장 보고서 하이라이트

구획증후군 치료 시장은 그 시급성과 치료 필요성이 높아 급성기 치료가 시장을 주도하고 있지만, 만성기 치료는 이 질환에 대한 인식이 높아지고 진단 방법이 개선되면서 중요한 부문으로 부상하고 있습니다.

한편, 물리치료 분야는 회복과 기능적 결과를 개선하기 위한 보완적 치료로 급성장하고 있습니다.

투여 경로별로는 응급상황에 직접적이고 신속하게 대응할 수 있는 정맥주사 부문이 시장을 선도하고 있으며, 경구용 부문은 편리성과 장기 투여에 대한 적합성 때문에 선호되고 있습니다.

유통 채널별로는 병원 약국 부문이 구획증후군 치료 시장을 독점하고 있는데, 이는 주로 즉각적이고 전문적인 치료를 제공하는 역할을 하고 있기 때문입니다. 그러나 온라인 약국 부문은 편의성과 의약품에 대한 광범위한 접근성을 제공함에 따라 가장 높은 성장세를 보이고 있습니다.

북미는 높은 의료 인프라와 높은 인지도를 바탕으로 지배적인 지역인 반면, 아시아태평양은 의료 투자 증가와 유병률 증가로 인해 가장 빠르게 성장하는 시장입니다.

목차

제1장 서론

제2장 주요 요약

제3장 조사 방법

제4장 세게의 구획증후군 치료 시장 인사이트

  • 치료 유형 현황
  • 구획증후군 치료 시장 역학
    • 성장 촉진요인과 기회
    • 성장 억제요인과 과제
  • PESTEL 분석
  • 구획증후군 치료 시장 치료 유형 동향
  • 밸류체인 분석
  • COVID-19의 영향 분석

제5장 세계의 구획증후군 치료 시장 : 증후군 유형별

  • 주요 조사 결과
  • 서론
  • 급성
  • 만성

제6장 세계의 구획증후군 치료 시장 : 치료 유형별

  • 주요 조사 결과
  • 서론
  • 수술
  • 대증요법
  • 항염증제
  • 물리치료

제7장 세계의 구획증후군 치료 시장 : 투여 경로별

  • 주요 조사 결과
  • 서론
  • 경구
  • 비경구
  • 정맥주사

제8장 세계의 구획증후군 치료 시장 : 유통 채널별

  • 주요 조사 결과
  • 서론
  • 병원 약국
  • 소매 약국
  • 온라인 약국
  • 기타

제9장 세계의 구획증후군 치료 시장 : 지역별

  • 주요 조사 결과
  • 서론
    • 구획증후군 치료 시장 평가 : 지역별, 2019년-2032년
  • 북미
    • 북미 : 증후군 유형별, 2019년-2032년
    • 북미 : 치료 유형별, 2019년-2032년
    • 북미 : 투여 경로별, 2019년-2032년
    • 북미 : 유통 채널별, 2019년-2032년
    • 미국
    • 캐나다
  • 유럽
    • 유럽 : 증후군 유형별, 2019년-2032년
    • 유럽 : 치료 유형별, 2019년-2032년
    • 유럽 : 투여 경로별, 2019년-2032년
    • 유럽 : 유통 채널별, 2019년-2032년
    • 영국
    • 프랑스
    • 독일
    • 이탈리아
    • 스페인
    • 네덜란드
    • 러시아
    • 기타 유럽
  • 아시아태평양
    • 아시아태평양 : 증후군 유형별, 2019년-2032년
    • 아시아태평양 : 치료 유형별, 2019년-2032년
    • 아시아태평양 : 투여 경로별, 2019년-2032년
    • 아시아태평양 : 유통 채널별, 2019년-2032년
    • 중국
    • 인도
    • 말레이시아
    • 일본
    • 인도네시아
    • 한국
    • 호주
    • 기타 아시아태평양
  • 중동 및 아프리카
    • 중동 및 아프리카 : 증후군 유형별, 2019년-2032년
    • 중동 및 아프리카 : 치료 유형별, 2019년-2032년
    • 중동 및 아프리카 : 투여 경로별, 2019년-2032년
    • 중동 및 아프리카 : 유통 채널별, 2019년-2032년
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 남아프리카공화국
    • 기타 중동 및 아프리카
  • 라틴아메리카
    • 라틴아메리카 : 증후군 유형별, 2019년-2032년
    • 라틴아메리카 : 치료 유형별, 2019년-2032년
    • 라틴아메리카 : 투여 경로별, 2019년-2032년
    • 라틴아메리카 : 유통 채널별, 2019년-2032년
    • 멕시코
    • 브라질
    • 아르헨티나
    • 기타 라틴아메리카

제10장 경쟁 구도

  • 확대와 인수 분석
    • 확대
    • 인수
  • 제휴/협업/합의/공개

제11장 기업 개요

  • Zimmer Biomet
  • Stryker Corporation
  • DePuy Synthes(a subsidiary of Johnson & Johnson)
  • Smith & Nephew
  • B. Braun Melsungen AG
  • Medtronic
  • Conmed Corporation
  • 3M Health Care
  • Integra LifeSciences
  • Bioventus
  • Orthofix Medical Inc.
  • Arthrex, Inc.
  • Teleflex Incorporated
LSH 24.11.20

The global compartment syndrome treatment market size is expected to reach USD 387.65million by 2032, according to a new study by Polaris Market Research. The report "Compartment Syndrome Treatment Market Size, Share, Trends, Industry Analysis Report: By Syndrome Type (Acute and Chronic), Treatment Type (Surgery, Supportive Treatment, Anti-Inflammatory Medications, and Physiotherapy), Route of Administration (Oral, Parenteral, and Intravenous), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2024-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The compartment syndrome treatment market growth is driven by increasing awareness of the condition, advancements in medical technology, rising incidences of traumatic injuries, and growing prevalence of chronic conditions that lead to compartment syndrome. The development of innovative treatment options, such as improved surgical techniques and advanced wound care products, and the growing demand for minimally invasive procedures also fuel the market growth.

Expanding market access to underserved regions and integrating new technologies such as artificial intelligence and robotics into treatment plans are expected to create opportunities for the market during the forecast period. Rising focus on personalized medicine and enhanced diagnostics for effective and targeted therapies would emerge as a key future trend in the market. Overall, the compartment syndrome treatment market is expected to expand significantly due to continuous advancements and increasing healthcare investments.

Compartment Syndrome Treatment Market Report Highlights

In terms of syndrome type, the acute segment dominates the compartment syndrome treatment market due to its urgent nature and higher treatment needs, while chronic is emerging as a significant segment owing to the rising awareness of the disease and improvements in its diagnosis options.

Surgery remains the most prevalent treatment method, driven by its effectiveness in addressing severe cases, whereas the physiotherapy segment is growing rapidly as a complementary treatment to improve recovery and functional outcomes.

By route of administration, the intravenous segment is leading the market due to its direct and rapid action in emergency situations, while the oral segment is gaining traction for its convenience and suitability for long-term management.

The hospital pharmacies segment, by distribution channel, dominates the compartment syndrome treatment market, primarily due to their role in providing immediate and specialized treatments. However, the online pharmacies segment is experiencing the highest growth as they offer convenience and broader access to medications.

North America is the dominant region, benefiting from advanced healthcare infrastructure and high awareness, whereas Asia Pacific has the fastest-growing market due to increasing healthcare investments and rising prevalence of the condition.

Polaris Market Research has segmented the compartment syndrome treatment market report on the basis of syndrome type, treatment type, route of administration, distribution channels, and region

By Syndrome Type Outlook (Revenue - USD Million, 2019-2032)

Acute

Chronic

By Treatment Type Outlook (Revenue - USD Million, 2019-2032)

Surgery

Supportive Treatment

Anti-Inflammatory Medications

Physiotherapy

By Route of Administration Outlook (Revenue - USD Million, 2019-2032)

Oral

Parenteral

Intravenous

By Distribution Channel Outlook (Revenue - USD Million, 2019-2032)

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

By Regional Outlook (Revenue - USD Million, 2019-2032)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Compartment Syndrome Treatment Market Insights

  • 4.1. Compartment Syndrome Treatment Market - Treatment Type Snapshot
  • 4.2. Compartment Syndrome Treatment Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Integration of Advanced Monitoring Technologies
      • 4.2.1.2. Growing Awareness and Training Among Healthcare Professionals
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Surgical Costs are hindering the Compartment Syndrome Treatment market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Compartment Syndrome Treatment Market Treatment Type Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Compartment Syndrome Treatment Market, by Syndrome Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Compartment Syndrome Treatment Market, by Syndrome Type, 2019-2032 (USD Million)
  • 5.3. Acute
    • 5.3.1. Global Compartment Syndrome Treatment Market, by Acute, by Region, 2019-2032 (USD Million)
  • 5.4. Chronic
    • 5.4.1. Global Compartment Syndrome Treatment Market, by Chronic, by Region, 2019-2032 (USD Million)

6. Global Compartment Syndrome Treatment Market, by Treatment Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Compartment Syndrome Treatment Market, by Treatment Type, 2019-2032 (USD Million)
  • 6.3. Surgery
    • 6.3.1. Global Compartment Syndrome Treatment Market, by Surgery, by Region, 2019-2032 (USD Million)
  • 6.4. Supportive Treatment
    • 6.4.1. Global Compartment Syndrome Treatment Market, by Supportive Treatment, by Region, 2019-2032 (USD Million)
  • 6.5. Anti-Inflammatory Medications
    • 6.5.1. Global Compartment Syndrome Treatment Market, by Anti-Inflammatory Medications, by Region, 2019-2032 (USD Million)
  • 6.6. Physiotherapy
    • 6.6.1. Global Compartment Syndrome Treatment Market, by Physiotherapy, by Region, 2019-2032 (USD Million)

7. Global Compartment Syndrome Treatment Market, by Route of Administration

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Compartment Syndrome Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • 7.3. Oral
    • 7.3.1. Global Compartment Syndrome Treatment Market, by Oral, by Region, 2019-2032 (USD Million)
  • 7.4. Parenteral
    • 7.4.1. Global Compartment Syndrome Treatment Market, by Parenteral, by Region, 2019-2032 (USD Million)
  • 7.5. Intravenous
    • 7.5.1. Global Compartment Syndrome Treatment Market, by Intravenous, by Region, 2019-2032 (USD Million)

8. Global Compartment Syndrome Treatment Market, by Distribution Channel

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Compartment Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • 8.3. Hospital Pharmacies
    • 8.3.1. Global Compartment Syndrome Treatment Market, by Hospital Pharmacies, by Region, 2019-2032 (USD Million)
  • 8.4. Retail Pharmacies
    • 8.4.1. Global Compartment Syndrome Treatment Market, by Retail Pharmacies, by Region, 2019-2032 (USD Million)
  • 8.5. Online Pharmacies
    • 8.5.1. Global Compartment Syndrome Treatment Market, by Online Pharmacies, by Region, 2019-2032 (USD Million)
  • 8.6. Others
    • 8.6.1. Global Compartment Syndrome Treatment Market, by Others, by Region, 2019-2032 (USD Million)

9. Global Compartment Syndrome Treatment Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Compartment Syndrome Treatment Market Assessment, By Geography, 2019-2032 (USD Million)
  • 9.3. Compartment Syndrome Treatment Market - North America
    • 9.3.1. North America: Compartment Syndrome Treatment Market, by Syndrome Type, 2019-2032 (USD Million)
    • 9.3.2. North America: Compartment Syndrome Treatment Market, by Treatment Type, 2019-2032 (USD Million)
    • 9.3.3. North America: Compartment Syndrome Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 9.3.4. North America: Compartment Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
    • 9.3.5. Compartment Syndrome Treatment Market - U.S.
      • 9.3.5.1. U.S.: Compartment Syndrome Treatment Market, by Syndrome Type, 2019-2032 (USD Million)
      • 9.3.5.2. U.S.: Compartment Syndrome Treatment Market, by Treatment Type, 2019-2032 (USD Million)
      • 9.3.5.3. U.S.: Compartment Syndrome Treatment Market, by Route of Administration, 2019-2032 (USD Million)
      • 9.3.5.4. U.S.: Compartment Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
    • 9.3.6. Compartment Syndrome Treatment Market - Canada
      • 9.3.6.1. Canada: Compartment Syndrome Treatment Market, by Syndrome Type, 2019-2032 (USD Million)
      • 9.3.6.2. Canada: Compartment Syndrome Treatment Market, by Treatment Type, 2019-2032 (USD Million)
      • 9.3.6.3. Canada: Compartment Syndrome Treatment Market, by Route of Administration, 2019-2032 (USD Million)
      • 9.3.6.4. Canada: Compartment Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • 9.4. Compartment Syndrome Treatment Market - Europe
    • 9.4.1. Europe: Compartment Syndrome Treatment Market, by Syndrome Type, 2019-2032 (USD Million)
    • 9.4.2. Europe: Compartment Syndrome Treatment Market, by Treatment Type, 2019-2032 (USD Million)
    • 9.4.3. Europe: Compartment Syndrome Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 9.4.4. Europe: Compartment Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
    • 9.4.5. Compartment Syndrome Treatment Market - UK
      • 9.4.5.1. UK: Compartment Syndrome Treatment Market, by Syndrome Type, 2019-2032 (USD Million)
      • 9.4.5.2. UK: Compartment Syndrome Treatment Market, by Treatment Type, 2019-2032 (USD Million)
      • 9.4.5.3. UK: Compartment Syndrome Treatment Market, by Route of Administration, 2019-2032 (USD Million)
      • 9.4.5.4. UK: Compartment Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
    • 9.4.6. Compartment Syndrome Treatment Market - France
      • 9.4.6.1. France: Compartment Syndrome Treatment Market, by Syndrome Type, 2019-2032 (USD Million)
      • 9.4.6.2. France: Compartment Syndrome Treatment Market, by Treatment Type, 2019-2032 (USD Million)
      • 9.4.6.3. France: Compartment Syndrome Treatment Market, by Route of Administration, 2019-2032 (USD Million)
      • 9.4.6.4. France: Compartment Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
    • 9.4.7. Compartment Syndrome Treatment Market - Germany
      • 9.4.7.1. Germany: Compartment Syndrome Treatment Market, by Syndrome Type, 2019-2032 (USD Million)
      • 9.4.7.2. Germany: Compartment Syndrome Treatment Market, by Treatment Type, 2019-2032 (USD Million)
      • 9.4.7.3. Germany: Compartment Syndrome Treatment Market, by Route of Administration, 2019-2032 (USD Million)
      • 9.4.7.4. Germany: Compartment Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
    • 9.4.8. Compartment Syndrome Treatment Market - Italy
      • 9.4.8.1. Italy: Compartment Syndrome Treatment Market, by Syndrome Type, 2019-2032 (USD Million)
      • 9.4.8.2. Italy: Compartment Syndrome Treatment Market, by Treatment Type, 2019-2032 (USD Million)
      • 9.4.8.3. Italy: Compartment Syndrome Treatment Market, by Route of Administration, 2019-2032 (USD Million)
      • 9.4.8.4. Italy: Compartment Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
    • 9.4.9. Compartment Syndrome Treatment Market - Spain
      • 9.4.9.1. Spain: Compartment Syndrome Treatment Market, by Syndrome Type, 2019-2032 (USD Million)
      • 9.4.9.2. Spain: Compartment Syndrome Treatment Market, by Treatment Type, 2019-2032 (USD Million)
      • 9.4.9.3. Spain: Compartment Syndrome Treatment Market, by Route of Administration, 2019-2032 (USD Million)
      • 9.4.9.4. Spain: Compartment Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
    • 9.4.10. Compartment Syndrome Treatment Market - Netherlands
      • 9.4.10.1. Netherlands: Compartment Syndrome Treatment Market, by Syndrome Type, 2019-2032 (USD Million)
      • 9.4.10.2. Netherlands: Compartment Syndrome Treatment Market, by Treatment Type, 2019-2032 (USD Million)
      • 9.4.10.3. Netherlands: Compartment Syndrome Treatment Market, by Route of Administration, 2019-2032 (USD Million)
      • 9.4.10.4. Netherlands: Compartment Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
    • 9.4.11. Compartment Syndrome Treatment Market - Russia
      • 9.4.11.1. Russia: Compartment Syndrome Treatment Market, by Syndrome Type, 2019-2032 (USD Million)
      • 9.4.11.2. Russia: Compartment Syndrome Treatment Market, by Treatment Type, 2019-2032 (USD Million)
      • 9.4.11.3. Russia: Compartment Syndrome Treatment Market, by Route of Administration, 2019-2032 (USD Million)
      • 9.4.11.4. Russia: Compartment Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
    • 9.4.12. Compartment Syndrome Treatment Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Compartment Syndrome Treatment Market, by Syndrome Type, 2019-2032 (USD Million)
      • 9.4.12.2. Rest of Europe: Compartment Syndrome Treatment Market, by Treatment Type, 2019-2032 (USD Million)
      • 9.4.12.3. Rest of Europe: Compartment Syndrome Treatment Market, by Route of Administration, 2019-2032 (USD Million)
      • 9.4.12.4. Rest of Europe: Compartment Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • 9.5. Compartment Syndrome Treatment Market - Asia Pacific
    • 9.5.1. Asia Pacific: Compartment Syndrome Treatment Market, by Syndrome Type, 2019-2032 (USD Million)
    • 9.5.2. Asia Pacific: Compartment Syndrome Treatment Market, by Treatment Type, 2019-2032 (USD Million)
    • 9.5.3. Asia Pacific: Compartment Syndrome Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 9.5.4. Asia Pacific: Compartment Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
    • 9.5.5. Compartment Syndrome Treatment Market - China
      • 9.5.5.1. China: Compartment Syndrome Treatment Market, by Syndrome Type, 2019-2032 (USD Million)
      • 9.5.5.2. China: Compartment Syndrome Treatment Market, by Treatment Type, 2019-2032 (USD Million)
      • 9.5.5.3. China: Compartment Syndrome Treatment Market, by Route of Administration, 2019-2032 (USD Million)
      • 9.5.5.4. China: Compartment Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
    • 9.5.6. Compartment Syndrome Treatment Market - India
      • 9.5.6.1. India: Compartment Syndrome Treatment Market, by Syndrome Type, 2019-2032 (USD Million)
      • 9.5.6.2. India: Compartment Syndrome Treatment Market, by Treatment Type, 2019-2032 (USD Million)
      • 9.5.6.3. India: Compartment Syndrome Treatment Market, by Route of Administration, 2019-2032 (USD Million)
      • 9.5.6.4. India: Compartment Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
    • 9.5.7. Compartment Syndrome Treatment Market - Malaysia
      • 9.5.7.1. Malaysia: Compartment Syndrome Treatment Market, by Syndrome Type, 2019-2032 (USD Million)
      • 9.5.7.2. Malaysia: Compartment Syndrome Treatment Market, by Treatment Type, 2019-2032 (USD Million)
      • 9.5.7.3. Malaysia: Compartment Syndrome Treatment Market, by Route of Administration, 2019-2032 (USD Million)
      • 9.5.7.4. Malaysia: Compartment Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
    • 9.5.8. Compartment Syndrome Treatment Market - Japan
      • 9.5.8.1. Japan: Compartment Syndrome Treatment Market, by Syndrome Type, 2019-2032 (USD Million)
      • 9.5.8.2. Japan: Compartment Syndrome Treatment Market, by Treatment Type, 2019-2032 (USD Million)
      • 9.5.8.3. Japan: Compartment Syndrome Treatment Market, by Route of Administration, 2019-2032 (USD Million)
      • 9.5.8.4. Japan: Compartment Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
    • 9.5.9. Compartment Syndrome Treatment Market - Indonesia
      • 9.5.9.1. Indonesia: Compartment Syndrome Treatment Market, by Syndrome Type, 2019-2032 (USD Million)
      • 9.5.9.2. Indonesia: Compartment Syndrome Treatment Market, by Treatment Type, 2019-2032 (USD Million)
      • 9.5.9.3. Indonesia: Compartment Syndrome Treatment Market, by Route of Administration, 2019-2032 (USD Million)
      • 9.5.9.4. Indonesia: Compartment Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
    • 9.5.10. Compartment Syndrome Treatment Market - South Korea
      • 9.5.10.1. South Korea: Compartment Syndrome Treatment Market, by Syndrome Type, 2019-2032 (USD Million)
      • 9.5.10.2. South Korea: Compartment Syndrome Treatment Market, by Treatment Type, 2019-2032 (USD Million)
      • 9.5.10.3. South Korea: Compartment Syndrome Treatment Market, by Route of Administration, 2019-2032 (USD Million)
      • 9.5.10.4. South Korea: Compartment Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
    • 9.5.11. Compartment Syndrome Treatment Market - Australia
      • 9.5.11.1. Australia: Compartment Syndrome Treatment Market, by Syndrome Type, 2019-2032 (USD Million)
      • 9.5.11.2. Australia: Compartment Syndrome Treatment Market, by Treatment Type, 2019-2032 (USD Million)
      • 9.5.11.3. Australia: Compartment Syndrome Treatment Market, by Route of Administration, 2019-2032 (USD Million)
      • 9.5.11.4. Australia: Compartment Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
    • 9.5.12. Compartment Syndrome Treatment Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Compartment Syndrome Treatment Market, by Syndrome Type, 2019-2032 (USD Million)
      • 9.5.12.2. Rest of Asia Pacific: Compartment Syndrome Treatment Market, by Treatment Type, 2019-2032 (USD Million)
      • 9.5.12.3. Rest of Asia Pacific: Compartment Syndrome Treatment Market, by Route of Administration, 2019-2032 (USD Million)
      • 9.5.12.4. Rest of Asia Pacific: Compartment Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • 9.6. Compartment Syndrome Treatment Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Compartment Syndrome Treatment Market, by Syndrome Type, 2019-2032 (USD Million)
    • 9.6.2. Middle East & Africa: Compartment Syndrome Treatment Market, by Treatment Type, 2019-2032 (USD Million)
    • 9.6.3. Middle East & Africa: Compartment Syndrome Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 9.6.4. Middle East & Africa: Compartment Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
    • 9.6.5. Compartment Syndrome Treatment Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Compartment Syndrome Treatment Market, by Syndrome Type, 2019-2032 (USD Million)
      • 9.6.5.2. Saudi Arabia: Compartment Syndrome Treatment Market, by Treatment Type, 2019-2032 (USD Million)
      • 9.6.5.3. Saudi Arabia: Compartment Syndrome Treatment Market, by Route of Administration, 2019-2032 (USD Million)
      • 9.6.5.4. Saudi Arabia: Compartment Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
    • 9.6.6. Compartment Syndrome Treatment Market - UAE
      • 9.6.6.1. UAE: Compartment Syndrome Treatment Market, by Syndrome Type, 2019-2032 (USD Million)
      • 9.6.6.2. UAE: Compartment Syndrome Treatment Market, by Treatment Type, 2019-2032 (USD Million)
      • 9.6.6.3. UAE: Compartment Syndrome Treatment Market, by Route of Administration, 2019-2032 (USD Million)
      • 9.6.6.4. UAE: Compartment Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
    • 9.6.7. Compartment Syndrome Treatment Market - Israel
      • 9.6.7.1. Israel: Compartment Syndrome Treatment Market, by Syndrome Type, 2019-2032 (USD Million)
      • 9.6.7.2. Israel: Compartment Syndrome Treatment Market, by Treatment Type, 2019-2032 (USD Million)
      • 9.6.7.3. Israel: Compartment Syndrome Treatment Market, by Route of Administration, 2019-2032 (USD Million)
      • 9.6.7.4. Israel: Compartment Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
    • 9.6.8. Compartment Syndrome Treatment Market - South Africa
      • 9.6.8.1. South Africa: Compartment Syndrome Treatment Market, by Syndrome Type, 2019-2032 (USD Million)
      • 9.6.8.2. South Africa: Compartment Syndrome Treatment Market, by Treatment Type, 2019-2032 (USD Million)
      • 9.6.8.3. South Africa: Compartment Syndrome Treatment Market, by Route of Administration, 2019-2032 (USD Million)
      • 9.6.8.4. South Africa: Compartment Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
    • 9.6.9. Compartment Syndrome Treatment Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Compartment Syndrome Treatment Market, by Syndrome Type, 2019-2032 (USD Million)
      • 9.6.9.2. Rest of Middle East & Africa: Compartment Syndrome Treatment Market, by Treatment Type, 2019-2032 (USD Million)
      • 9.6.9.3. Rest of Middle East & Africa: Compartment Syndrome Treatment Market, by Route of Administration, 2019-2032 (USD Million)
      • 9.6.9.4. Rest of Middle East & Africa: Compartment Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • 9.7. Compartment Syndrome Treatment Market - Latin America
    • 9.7.1. Latin America: Compartment Syndrome Treatment Market, by Syndrome Type, 2019-2032 (USD Million)
    • 9.7.2. Latin America: Compartment Syndrome Treatment Market, by Treatment Type, 2019-2032 (USD Million)
    • 9.7.3. Latin America: Compartment Syndrome Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 9.7.4. Latin America: Compartment Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
    • 9.7.5. Compartment Syndrome Treatment Market - Mexico
      • 9.7.5.1. Mexico: Compartment Syndrome Treatment Market, by Syndrome Type, 2019-2032 (USD Million)
      • 9.7.5.2. Mexico: Compartment Syndrome Treatment Market, by Treatment Type, 2019-2032 (USD Million)
      • 9.7.5.3. Mexico: Compartment Syndrome Treatment Market, by Route of Administration, 2019-2032 (USD Million)
      • 9.7.5.4. Mexico: Compartment Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
    • 9.7.6. Compartment Syndrome Treatment Market - Brazil
      • 9.7.6.1. Brazil: Compartment Syndrome Treatment Market, by Syndrome Type, 2019-2032 (USD Million)
      • 9.7.6.2. Brazil: Compartment Syndrome Treatment Market, by Treatment Type, 2019-2032 (USD Million)
      • 9.7.6.3. Brazil: Compartment Syndrome Treatment Market, by Route of Administration, 2019-2032 (USD Million)
      • 9.7.6.4. Brazil: Compartment Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
    • 9.7.7. Compartment Syndrome Treatment Market - Argentina
      • 9.7.7.1. Argentina: Compartment Syndrome Treatment Market, by Syndrome Type, 2019-2032 (USD Million)
      • 9.7.7.2. Argentina: Compartment Syndrome Treatment Market, by Treatment Type, 2019-2032 (USD Million)
      • 9.7.7.3. Argentina: Compartment Syndrome Treatment Market, by Route of Administration, 2019-2032 (USD Million)
      • 9.7.7.4. Argentina: Compartment Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
    • 9.7.8. Compartment Syndrome Treatment Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Compartment Syndrome Treatment Market, by Syndrome Type, 2019-2032 (USD Million)
      • 9.7.8.2. Rest of Latin America: Compartment Syndrome Treatment Market, by Treatment Type, 2019-2032 (USD Million)
      • 9.7.8.3. Rest of Latin America: Compartment Syndrome Treatment Market, by Route of Administration, 2019-2032 (USD Million)
      • 9.7.8.4. Rest of Latin America: Compartment Syndrome Treatment Market, by Distribution Channel, 2019-2032 (USD Million)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Zimmer Biomet
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Stryker Corporation
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. DePuy Synthes (a subsidiary of Johnson & Johnson)
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Smith & Nephew
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. B. Braun Melsungen AG
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Medtronic
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Conmed Corporation
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. 3M Health Care
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Integra LifeSciences
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Bioventus
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Orthofix Medical Inc.
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Arthrex, Inc.
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. Teleflex Incorporated
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제